These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36434292)

  • 21. Therapeutic drug monitoring and receiver operating characteristic curve prediction may reduce the development of linezolid-associated thrombocytopenia in critically ill patients.
    Dong HY; Xie J; Chen LH; Wang TT; Zhao YR; Dong YL
    Eur J Clin Microbiol Infect Dis; 2014 Jun; 33(6):1029-35. PubMed ID: 24515096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initial trough concentration may be beneficial in preventing linezolid-induced thrombocytopenia.
    Komatsu T; Nakamura M; Uchiyama K; Inoue G; Sakanoue K; Kawamura A; Hiratsuka K; Takayama Y; Takaso M; Atsuda K
    J Chemother; 2022 Oct; 34(6):375-380. PubMed ID: 35209803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of high plasma concentrations of linezolid in Taiwanese adult patients- therapeutic drug monitoring in improving adverse drug reactions.
    Cheng CN; Wu CC; Kuo CH; Wang CC; Wang JT; Lin YT; Jhang RS; Lin SW
    J Formos Med Assoc; 2021 Jan; 120(1 Pt 2):466-475. PubMed ID: 32600864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Linezolid-Associated Thrombocytopenia in Children With Renal Impairment.
    Jones SJ; Nichols KR; DeYoung HL; Cox EG; Knoderer CA
    J Pediatric Infect Dis Soc; 2015 Sep; 4(3):272-5. PubMed ID: 26407433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for linezolid-induced thrombocytopenia in adult inpatients.
    Han X; Wang J; Zan X; Peng L; Nie X
    Int J Clin Pharm; 2022 Apr; 44(2):330-338. PubMed ID: 34731363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombocytopenia Associated with Linezolid Therapy in Solid Organ Transplant Recipients: A Retrospective Cohort Study.
    Tessier JM; Puzio T; Young A; Wolfe L; Han J; Duane TM
    Surg Infect (Larchmt); 2015 Aug; 16(4):361-7. PubMed ID: 26207396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for linezolid-induced thrombocytopenia in patients without haemato-oncologic diseases.
    Choi GW; Lee JY; Chang MJ; Kim YK; Cho Y; Yu YM; Lee E
    Basic Clin Pharmacol Toxicol; 2019 Feb; 124(2):228-234. PubMed ID: 30171804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for thrombocytopenia in patients receiving linezolid therapy: a systematic review and meta-analysis.
    Zhang D; Xu Y; Wang X; Hou L; Xing M; Xu S; Guo R; Luo Y
    Eur J Clin Pharmacol; 2023 Oct; 79(10):1303-1314. PubMed ID: 37578552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors associated with high linezolid trough plasma concentrations.
    Morata L; De la Calle C; Gómez-Cerquera JM; Manzanedo L; Casals G; Brunet M; Cobos-Trigueros N; Martínez JA; Mensa J; Soriano A
    Expert Opin Pharmacother; 2016 Jun; 17(9):1183-7. PubMed ID: 27156708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retrospective analysis of the risk factors for linezolid-induced thrombocytopenia in adult Japanese patients.
    Hirano R; Sakamoto Y; Tachibana N; Ohnishi M
    Int J Clin Pharm; 2014 Aug; 36(4):795-9. PubMed ID: 24913359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A retrospective study of the risk factors for linezolid-induced thrombocytopenia and anemia.
    Hanai Y; Matsuo K; Ogawa M; Higashi A; Kimura I; Hirayama S; Kosugi T; Nishizawa K; Yoshio T
    J Infect Chemother; 2016 Aug; 22(8):536-42. PubMed ID: 27321773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A retrospective test for a possible relationship between linezolid-induced thrombocytopenia and hyponatraemia.
    Tanaka R; Suzuki Y; Morinaga Y; Iwao M; Takumi Y; Hashinaga K; Tatsuta R; Hiramatsu K; Kadota JI; Itoh H
    J Clin Pharm Ther; 2021 Apr; 46(2):343-351. PubMed ID: 33016566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal replacement therapy and concurrent fluconazole therapy increase linezolid-related thrombocytopenia among adult patients.
    Hsu YC; Chen SY; Hung YJ; Huang YW
    Sci Rep; 2022 Jun; 12(1):9894. PubMed ID: 35701469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for linezolid-associated thrombocytopenia and negative effect of carbapenem combination.
    Kaya Kılıç E; Bulut C; Sönmezer MÇ; Ozel Ö; Ataman Hatipoğlu Ç; Tuncer Ertem G; Tülek N; Kınıklı S
    J Infect Dev Ctries; 2019 Oct; 13(10):886-891. PubMed ID: 32084018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does the conventional dosage of linezolid necessitate therapeutic drug monitoring?-Experience from a prospective observational study.
    Fang J; Chen C; Wu Y; Zhang M; Zhang Y; Shi G; Yao Y; Chen H; Bian X
    Ann Transl Med; 2020 Apr; 8(7):493. PubMed ID: 32395537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics, toxicity and clinical efficacy of linezolid in Japanese pediatric patients.
    Ogami C; Tsuji Y; To H; Yamamoto Y
    J Infect Chemother; 2019 Dec; 25(12):979-986. PubMed ID: 31208925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Risk factors for development of hematotoxicity in elderly patients treated with Linezolid].
    Bo SY; Su AM; Yang F; Yang L
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 Jun; 45(6):533-538. PubMed ID: 35658376
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacokinetic and pharmacodynamic simulation for the quantitative risk assessment of linezolid-associated thrombocytopenia.
    Onita T; Ishihara N; Ikebuchi A; Yano T; Nishimura N; Tamaki H; Ikawa K; Morikawa N; Naora K
    J Clin Pharm Ther; 2022 Dec; 47(12):2041-2048. PubMed ID: 35893441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and validation of a risk prediction model for linezolid-induced thrombocytopenia in elderly patients.
    Qin Y; Chen Z; Gao S; Shen Y; Ye Y
    Eur J Hosp Pharm; 2024 Feb; 31(2):94-100. PubMed ID: 35477677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association between risk factors and time of onset for thrombocytopenia in Japanese patients receiving linezolid therapy: a retrospective analysis.
    Ichie T; Suzuki D; Yasui K; Takahashi H; Matsuda M; Hayashi H; Sugiura Y; Sugiyama T
    J Clin Pharm Ther; 2015 Jun; 40(3):279-84. PubMed ID: 25732525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.